BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Deals

  Generational Equity Advises LGM Pharma in its Sale to New Harbor Capital

  Generational Equity is pleased to announce a majority acquisition of its client, LGM Pharma, by New Harbor Capital LLC.

  December 6, 2017

   · 

  2 min read
• Business

  Tango Therapeutics Announces the Addition of Shakti Narayan, Ph.D., J.D. as Chief Business Officer

  Narayan brings extensive leadership experience in business development, operations and legal operations within the biotechnology and pharmaceuticals industries, most recently through his role as Vice President and Head of Transactions at Johnson & Johnson (J&J) Innovation in Boston.

  December 6, 2017

   · 

  2 min read
• Pharm Country

  AstraZeneca to Highlight Its Commitment to Blood Cancers at the 2017 American Society of Hematology Annual Meeting

  CALQUENCE (acalabrutinib) is a kinase inhibitor indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.

  December 6, 2017

   · 

  11 min read
• Business

  Relevium Signs Exclusivity Agreement for Provinal Ultra-Purified Omega 7

  An option for an agreement extension will be evaluated, considered and negotiated by Tersus and Relevium, subject to the fulfillment of the two (2) year Agreement Terms.

  December 6, 2017

   · 

  6 min read
• Business

  General Partner AmorChem II Ventures Announces Establishment and Launch of New Fund, AmorChem II Fund L.P.

  AmorChem II is backed by the following limited partners: the Québec government, Fonds de solidarité FTQ, Merck and other qualified investors.

  December 6, 2017

   · 

  4 min read
• Business

  Genomic Health Announces Research Collaboration With Janssen to Evaluate the Oncotype DX Genomic Prostate Score Test for Potential Drug Development

  As part of the agreement, Genomic Health will test samples from Janssen studies to examine the association of GPS results with clinical outcomes.

  December 6, 2017

   · 

  4 min read
• Drug Development

  PaxVax’s Randomized Placebo-Controlled Study Provides Encouraging Results for a Higher Dose Formulation of Vaxchora (CVD 103-HgR) as a Potential Tool in Containing Cholera Epidemics

  Results support potential future development of a new formulation of Vaxchora as an important additional tool for global cholera control in developing countries.

  December 6, 2017

   · 

  6 min read
• Biotech Beach

  Biocept Announces Pricing of Public Offering of up to 4,925,936 Shares of Common Stock

  No warrants to purchase shares of the Company’s common stock will be issued to the investors in connection with the offering.

  December 6, 2017

   · 

  4 min read
• Business

  Charles River Adds ERS License to CRISPR/Cas9 Service Offering

  The license, coupled with the existing license through the Broad Institute of MIT and Harvard, allows Charles River to offer custom in vivo and in vitro genome editing.

  December 6, 2017

   · 

  2 min read
• Next-Generation High-Definition Visualization System for Minimally Invasive Surgery Introduced by DePuy Synthes

  Today, the PUREVUE Visualization System was unveiled at the Orthopaedic Summit 2017.

  December 6, 2017

   · 

  2 min read